Client’s Testimonial:
“Thank you so much for the amazing news! My experience with the firm has been nothing short of excellent! Very good service and good turnaround. Thank you!”
On March 20th, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Scientist in the Field of Protein Science and Biopharmaceuticals (Approval Notice).
General Field: Protein Science and Biopharmaceuticals
Position at the Time of Case Filing: Senior Scientist
Country of Origin: China
State of Residence at the Time of Filing: Maryland
Approval Notice Date: March 20th, 2024
Processing Time: 5 days (Premium Processing Requested)
Case Summary:
Armed with a Ph.D. in chemical engineering, our client, a distinguished senior scientist, demonstrated exceptional expertise in advancing research within the field of protein science and biopharmaceuticals. Seeking our assistance in navigating the I-140 NIW (National Interest Waiver) petition process, we delved into evaluating her qualifications. Drawing insights from her research achievements and professional triumphs, we were convinced that her proposed research endeavors held immense value in the United States. Our primary objective was to showcase to the USCIS the profound benefits her work could bring to the United States, thereby substantiating the need for her to secure the national interest waiver. To bolster our case, we strategically emphasized several pivotal points:
- We indicated our client’s publications which have been cited 20 times from the 5 peer-reviewed journal articles (4 of them first-authored), showing that her publications are noble and most-cited in the field of protein science and biopharmaceuticals.
- We detailed her research on developing biomanufacturing processes to produce therapeutic moieties like biologics, small molecules, and cell and gene therapies to achieve optimal-quality treatments for diseases such as cancer, inflammation, and rare diseases, which is of great importance because it focuses on improving the quality of treatments worldwide for diseases, such as cancer.
- Also, we noted how her work has also been supported by several federally-funded institutions such as the National Institute of Innovation in Manufacturing Biopharmaceuticals and the Defense Threat Reduction Agency. As a result, this study advances her greater objective of improving biomanufacturing processes to generate therapeutic moieties to obtain the highest-quality disease therapies possible.
- Besides, given that the high cost of cancer medications and a scarcity of experts continue to be important factors in cancer’s effect in LIMCs, incorporating our client’s biomanufacturing innovations expands the availability of top-tier therapies. Accordingly, with numerous advantages to improved biomanufacturing, her ongoing research plays a vital role in improving the quality and access to disease treatment globally.
- Lastly, we suggested to our client to arrange a few letters of support to bolster her case. Accordingly, we got four recommendation letters acquired from her from fellow researchers, one of whom contributed the following statement:
“Her field experiences and educational background in chemical engineering have honed her skills in experimentation, including the use of biochemical assays and cell culture, as well as her computational proficiencies in areas like machine learning, modeling, and simulation. Based on the rigor of her knowledge and skill set, it is clear that [our client] is an asset to the American scientific community.”
With her exceptional expertise in therapeutic protein production and process development, groundbreaking research, and significant contributions to advancing biomanufacturing processes, it is crystal clear that she is leading the way in her field. Our successful communication with the USCIS highlighted the tremendous value of her work, which focuses on the cost-effective production of vital therapeutic products, including biologics for treating diseases like cancer.
Therefore, USCIS swiftly approved her NIW case in just 5 days, a testament to our unwavering support and dedication. We express our heartfelt gratitude to her for entrusting us with this process and allowing us to play a role in this remarkable achievement. Congratulations to her on reaching this important milestone.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.
If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation email: law@wegreened.com
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.